Clinical Trials

10 enrolled

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06393335 2024-05-01

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

36 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05370547 2024-03-06

Chidamide Bridging for CAR-T Therapy

120 enrolled

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin

NCT06277011 2024-02-26

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

18 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06170216 2024-02-23

Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)

220 enrolled

Lymphoma, Non-Hodgkin

NCT06206902 2024-02-23

F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

55 enrolled

Lymphoma, Non-Hodgkin

NCT03650933 2024-02-20

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Phase 3 Unknown

360 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05422521 2024-01-30

CART-Omic

Lymphoma, Non-Hodgkin

NCT05150405 2024-01-23

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

54 enrolled

Lymphoma, Non-Hodgkin

NCT05186012 2024-01-23

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

51 enrolled

Lymphoma, Non-Hodgkin

NCT05420493 2024-01-05

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

54 enrolled

Lymphoma, Non-Hodgkin

NCT04090268 2024-01-02

SportTherapy

380 enrolled

Adrenoleukodystrophy, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms, Sickle Cell Trait, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, beta-Thalassemia

NCT06160362 2023-12-07

The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

82 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05235633 2023-11-24

ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma

Leukemia, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms

NCT04758650 2023-11-18

MITRAS

140 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Sarcoidosis, Carotid Stenosis

NCT06049381 2023-09-22

Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research

22 enrolled

Lymphoma, Non-Hodgkin

NCT05005299 2023-08-01

VICTORY

LymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05487651 2023-05-18

ANCHOR2

LymphoidOther hematologic neoplasmSarcoma

36 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT04356846 2023-05-01

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

74 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05381181 2023-01-27

Safety and Efficacy Evaluation of Next-generation CD19-UCART

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05691153 2023-01-19

ThisCART19A for B-NHL Relapsed After Auto-CAR T

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT01811368 2022-11-30

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

NCT05415098 2022-11-16

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

90 enrolled

Nasopharyngeal Carcinoma, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Stomach Neoplasms, Lymphoma, B-Cell

NCT05606588 2022-11-04

PrepAIR

131 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

71 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT04502394 2022-08-04

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

84 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05363800 2022-07-29

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

198 enrolled

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence

NCT05477667 2022-07-28

Study of Let-7a and miRNA-124 in Cases of Non-Hodgkin's Lymphoma and Acute Leukemia

Lymphoma, Non-Hodgkin

NCT05410041 2022-06-08

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies

15 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03958916 2022-05-09

Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL

500 enrolled

Lymphoma, Non-Hodgkin, Neoplasms

NCT03971305 2022-05-09

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL

300 enrolled

Lymphoma, Non-Hodgkin, Neoplasms

NCT03971318 2022-05-09

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL

300 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05349266 2022-04-27

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

16 enrolled

Lymphoma, Non-Hodgkin

NCT05320640 2022-04-11

Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

Lymphoma, Non-Hodgkin

NCT04514393 2022-04-07

Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma

33 enrolled

Lymphoma, Non-Hodgkin

NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

Phase 4 Unknown

48 enrolled

Lymphoma, Non-Hodgkin

NCT05200312 2022-03-11

ZR2-CHOP

36 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05155839 2022-02-22

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

108 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT05206071 2022-01-25

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

NCT03505944 2021-10-13

VALERIA

59 enrolled

Lymphoma, Non-Hodgkin

NCT05066958 2021-10-04

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Virus Diseases, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05050630 2021-09-20

Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL

73 enrolled

Lymphoma, Non-Hodgkin

NCT05021770 2021-08-26

Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma

29 enrolled

Lymphoma, Non-Hodgkin

NCT00003337 2021-08-16

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Phase 3 Unknown

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003338 2021-08-16

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Phase 2/3 Unknown

60 enrolled

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04539444 2021-08-02

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

10 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT00324467 2021-07-22

LYTPET

150 enrolled

Lymphoma, Non-Hodgkin

NCT04923789 2021-06-11

A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

60 enrolled